Global Pneumococcal 13-valent Conjugate Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 95

Published Date: 28 Oct 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.

The global Pneumococcal 13-valent Conjugate Vaccine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Pneumococcal 13-valent Conjugate Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pneumococcal 13-valent Conjugate Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pneumococcal 13-valent Conjugate Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pneumococcal 13-valent Conjugate Vaccine total production and demand, 2019-2030, (K Units)
Global Pneumococcal 13-valent Conjugate Vaccine total production value, 2019-2030, (USD Million)
Global Pneumococcal 13-valent Conjugate Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Pneumococcal 13-valent Conjugate Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Pneumococcal 13-valent Conjugate Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pneumococcal 13-valent Conjugate Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Pneumococcal 13-valent Conjugate Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Pneumococcal 13-valent Conjugate Vaccine production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Pneumococcal 13-valent Conjugate Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Walvax, BIOKANGTAI, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pneumococcal 13-valent Conjugate Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Pneumococcal 13-valent Conjugate Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pneumococcal 13-valent Conjugate Vaccine Market, Segmentation by Type:
    0.5ml
    Other

Global Pneumococcal 13-valent Conjugate Vaccine Market, Segmentation by Application:
    Hospital
    Clinic

Companies Profiled:
    Pfizer
    Walvax
    BIOKANGTAI

Key Questions Answered:
1. How big is the global Pneumococcal 13-valent Conjugate Vaccine market?
2. What is the demand of the global Pneumococcal 13-valent Conjugate Vaccine market?
3. What is the year over year growth of the global Pneumococcal 13-valent Conjugate Vaccine market?
4. What is the production and production value of the global Pneumococcal 13-valent Conjugate Vaccine market?
5. Who are the key producers in the global Pneumococcal 13-valent Conjugate Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Pneumococcal 13-valent Conjugate Vaccine Introduction
    1.2 World Pneumococcal 13-valent Conjugate Vaccine Supply & Forecast
        1.2.1 World Pneumococcal 13-valent Conjugate Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030)
        1.2.3 World Pneumococcal 13-valent Conjugate Vaccine Pricing Trends (2019-2030)
    1.3 World Pneumococcal 13-valent Conjugate Vaccine Production by Region (Based on Production Site)
        1.3.1 World Pneumococcal 13-valent Conjugate Vaccine Production Value by Region (2019-2030)
        1.3.2 World Pneumococcal 13-valent Conjugate Vaccine Production by Region (2019-2030)
        1.3.3 World Pneumococcal 13-valent Conjugate Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030)
        1.3.5 Europe Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030)
        1.3.6 China Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030)
        1.3.7 Japan Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pneumococcal 13-valent Conjugate Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pneumococcal 13-valent Conjugate Vaccine Major Market Trends

2 Demand Summary
    2.1 World Pneumococcal 13-valent Conjugate Vaccine Demand (2019-2030)
    2.2 World Pneumococcal 13-valent Conjugate Vaccine Consumption by Region
        2.2.1 World Pneumococcal 13-valent Conjugate Vaccine Consumption by Region (2019-2024)
        2.2.2 World Pneumococcal 13-valent Conjugate Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)
    2.4 China Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)
    2.5 Europe Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)
    2.6 Japan Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)
    2.7 South Korea Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)
    2.8 ASEAN Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)
    2.9 India Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Pneumococcal 13-valent Conjugate Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Pneumococcal 13-valent Conjugate Vaccine Production by Manufacturer (2019-2024)
    3.3 World Pneumococcal 13-valent Conjugate Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Pneumococcal 13-valent Conjugate Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Pneumococcal 13-valent Conjugate Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Pneumococcal 13-valent Conjugate Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Pneumococcal 13-valent Conjugate Vaccine in 2023
    3.6 Pneumococcal 13-valent Conjugate Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Pneumococcal 13-valent Conjugate Vaccine Market: Region Footprint
        3.6.2 Pneumococcal 13-valent Conjugate Vaccine Market: Company Product Type Footprint
        3.6.3 Pneumococcal 13-valent Conjugate Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Value Comparison
        4.1.1 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Comparison
        4.2.1 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Consumption Comparison
        4.3.1 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Pneumococcal 13-valent Conjugate Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production (2019-2024)
    4.5 China Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers and Market Share
        4.5.1 China Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production (2019-2024)
    4.6 Rest of World Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Pneumococcal 13-valent Conjugate Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 0.5ml
        5.2.2 Other
    5.3 Market Segment by Type
        5.3.1 World Pneumococcal 13-valent Conjugate Vaccine Production by Type (2019-2030)
        5.3.2 World Pneumococcal 13-valent Conjugate Vaccine Production Value by Type (2019-2030)
        5.3.3 World Pneumococcal 13-valent Conjugate Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Pneumococcal 13-valent Conjugate Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Pneumococcal 13-valent Conjugate Vaccine Production by Application (2019-2030)
        6.3.2 World Pneumococcal 13-valent Conjugate Vaccine Production Value by Application (2019-2030)
        6.3.3 World Pneumococcal 13-valent Conjugate Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Pneumococcal 13-valent Conjugate Vaccine Product and Services
        7.1.4 Pfizer Pneumococcal 13-valent Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Walvax
        7.2.1 Walvax Details
        7.2.2 Walvax Major Business
        7.2.3 Walvax Pneumococcal 13-valent Conjugate Vaccine Product and Services
        7.2.4 Walvax Pneumococcal 13-valent Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Walvax Recent Developments/Updates
        7.2.6 Walvax Competitive Strengths & Weaknesses
    7.3 BIOKANGTAI
        7.3.1 BIOKANGTAI Details
        7.3.2 BIOKANGTAI Major Business
        7.3.3 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product and Services
        7.3.4 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 BIOKANGTAI Recent Developments/Updates
        7.3.6 BIOKANGTAI Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pneumococcal 13-valent Conjugate Vaccine Industry Chain
    8.2 Pneumococcal 13-valent Conjugate Vaccine Upstream Analysis
        8.2.1 Pneumococcal 13-valent Conjugate Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Pneumococcal 13-valent Conjugate Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Pneumococcal 13-valent Conjugate Vaccine Production Mode
    8.6 Pneumococcal 13-valent Conjugate Vaccine Procurement Model
    8.7 Pneumococcal 13-valent Conjugate Vaccine Industry Sales Model and Sales Channels
        8.7.1 Pneumococcal 13-valent Conjugate Vaccine Sales Model
        8.7.2 Pneumococcal 13-valent Conjugate Vaccine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Region (2019-2024)
 Table 5. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Region (2025-2030)
 Table 6. World Pneumococcal 13-valent Conjugate Vaccine Production by Region (2019-2024) & (K Units)
 Table 7. World Pneumococcal 13-valent Conjugate Vaccine Production by Region (2025-2030) & (K Units)
 Table 8. World Pneumococcal 13-valent Conjugate Vaccine Production Market Share by Region (2019-2024)
 Table 9. World Pneumococcal 13-valent Conjugate Vaccine Production Market Share by Region (2025-2030)
 Table 10. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Pneumococcal 13-valent Conjugate Vaccine Major Market Trends
 Table 13. World Pneumococcal 13-valent Conjugate Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Pneumococcal 13-valent Conjugate Vaccine Consumption by Region (2019-2024) & (K Units)
 Table 15. World Pneumococcal 13-valent Conjugate Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Pneumococcal 13-valent Conjugate Vaccine Producers in 2023
 Table 18. World Pneumococcal 13-valent Conjugate Vaccine Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Pneumococcal 13-valent Conjugate Vaccine Producers in 2023
 Table 20. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Pneumococcal 13-valent Conjugate Vaccine Company Evaluation Quadrant
 Table 22. World Pneumococcal 13-valent Conjugate Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Pneumococcal 13-valent Conjugate Vaccine Production Site of Key Manufacturer
 Table 24. Pneumococcal 13-valent Conjugate Vaccine Market: Company Product Type Footprint
 Table 25. Pneumococcal 13-valent Conjugate Vaccine Market: Company Product Application Footprint
 Table 26. Pneumococcal 13-valent Conjugate Vaccine Competitive Factors
 Table 27. Pneumococcal 13-valent Conjugate Vaccine New Entrant and Capacity Expansion Plans
 Table 28. Pneumococcal 13-valent Conjugate Vaccine Mergers & Acquisitions Activity
 Table 29. United States VS China Pneumococcal 13-valent Conjugate Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Pneumococcal 13-valent Conjugate Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Pneumococcal 13-valent Conjugate Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Market Share (2019-2024)
 Table 37. China Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Market Share (2019-2024)
 Table 42. Rest of World Based Pneumococcal 13-valent Conjugate Vaccine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Market Share (2019-2024)
 Table 47. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Pneumococcal 13-valent Conjugate Vaccine Production by Type (2019-2024) & (K Units)
 Table 49. World Pneumococcal 13-valent Conjugate Vaccine Production by Type (2025-2030) & (K Units)
 Table 50. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Pneumococcal 13-valent Conjugate Vaccine Production by Application (2019-2024) & (K Units)
 Table 56. World Pneumococcal 13-valent Conjugate Vaccine Production by Application (2025-2030) & (K Units)
 Table 57. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 62. Pfizer Major Business
 Table 63. Pfizer Pneumococcal 13-valent Conjugate Vaccine Product and Services
 Table 64. Pfizer Pneumococcal 13-valent Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Pfizer Recent Developments/Updates
 Table 66. Pfizer Competitive Strengths & Weaknesses
 Table 67. Walvax Basic Information, Manufacturing Base and Competitors
 Table 68. Walvax Major Business
 Table 69. Walvax Pneumococcal 13-valent Conjugate Vaccine Product and Services
 Table 70. Walvax Pneumococcal 13-valent Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Walvax Recent Developments/Updates
 Table 72. Walvax Competitive Strengths & Weaknesses
 Table 73. BIOKANGTAI Basic Information, Manufacturing Base and Competitors
 Table 74. BIOKANGTAI Major Business
 Table 75. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product and Services
 Table 76. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. BIOKANGTAI Recent Developments/Updates
 Table 78. BIOKANGTAI Competitive Strengths & Weaknesses
 Table 79. Global Key Players of Pneumococcal 13-valent Conjugate Vaccine Upstream (Raw Materials)
 Table 80. Global Pneumococcal 13-valent Conjugate Vaccine Typical Customers
 Table 81. Pneumococcal 13-valent Conjugate Vaccine Typical Distributors


List of Figures
 Figure 1. Pneumococcal 13-valent Conjugate Vaccine Picture
 Figure 2. World Pneumococcal 13-valent Conjugate Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Pneumococcal 13-valent Conjugate Vaccine Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030) & (K Units)
 Figure 5. World Pneumococcal 13-valent Conjugate Vaccine Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Region (2019-2030)
 Figure 7. World Pneumococcal 13-valent Conjugate Vaccine Production Market Share by Region (2019-2030)
 Figure 8. North America Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030) & (K Units)
 Figure 9. Europe Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030) & (K Units)
 Figure 10. China Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030) & (K Units)
 Figure 11. Japan Pneumococcal 13-valent Conjugate Vaccine Production (2019-2030) & (K Units)
 Figure 12. Pneumococcal 13-valent Conjugate Vaccine Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 15. World Pneumococcal 13-valent Conjugate Vaccine Consumption Market Share by Region (2019-2030)
 Figure 16. United States Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 17. China Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 18. Europe Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 19. Japan Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 22. India Pneumococcal 13-valent Conjugate Vaccine Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Pneumococcal 13-valent Conjugate Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Pneumococcal 13-valent Conjugate Vaccine Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Pneumococcal 13-valent Conjugate Vaccine Markets in 2023
 Figure 26. United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Pneumococcal 13-valent Conjugate Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Pneumococcal 13-valent Conjugate Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Market Share 2023
 Figure 30. China Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Pneumococcal 13-valent Conjugate Vaccine Production Market Share 2023
 Figure 32. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Type in 2023
 Figure 34. 0.5ml
 Figure 35. Other
 Figure 36. World Pneumococcal 13-valent Conjugate Vaccine Production Market Share by Type (2019-2030)
 Figure 37. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Type (2019-2030)
 Figure 38. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Type (2019-2030) & (US$/Unit)
 Figure 39. World Pneumococcal 13-valent Conjugate Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Application in 2023
 Figure 41. Hospital
 Figure 42. Clinic
 Figure 43. World Pneumococcal 13-valent Conjugate Vaccine Production Market Share by Application (2019-2030)
 Figure 44. World Pneumococcal 13-valent Conjugate Vaccine Production Value Market Share by Application (2019-2030)
 Figure 45. World Pneumococcal 13-valent Conjugate Vaccine Average Price by Application (2019-2030) & (US$/Unit)
 Figure 46. Pneumococcal 13-valent Conjugate Vaccine Industry Chain
 Figure 47. Pneumococcal 13-valent Conjugate Vaccine Procurement Model
 Figure 48. Pneumococcal 13-valent Conjugate Vaccine Sales Model
 Figure 49. Pneumococcal 13-valent Conjugate Vaccine Sales Channels, Direct Sales, and Distribution
 Figure 50. Methodology
 Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Walvax
BIOKANGTAI

Related Reports

Global Pneumococcal 13-valent Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pneumococcal 13-valent Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 28 Oct 2024

date Pharma & Healthcare

The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.

Product Tags

Pneumococcal 13-valent Conjugate Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>